Clinical Trials Browser

Phase 1 × Neoplasms × Testosterone × Clear all

NCT01187485 2023-11-29

A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer

Phase 1 Completed

Neoplasms, Prostatic Neoplasms